By transforming human scar cells into blood vessel cells, scientists at Houston Methodist may have discovered a new way to repair damaged tissue.
The method, described in an upcoming issue of Circulation (early online), appeared to improve blood flow, oxygenation, and nutrition to areas in need.
Cardiovascular scientists at Houston Methodist, with colleagues at Stanford University and Cincinnati Children’s Hospital, learned that fibroblasts — cells that causes scarring and are plentiful throughout the human body — can be coaxed into becoming endothelium, an entirely different type of adult cell that forms the lining of blood vessels.
“To our knowledge, this is the first time that trans-differentiation to a therapeutic cell type has been accomplished with a small molecules and proteins,” said Houston Methodist Research Institute Department of Cardiovascular Sciences Chair John Cooke, M.D., Ph.D., the study’s principal investigator. “In this particular case, we’ve found a way to turn fibroblasts into ‘shapeshifters’ nearly on command.”
Cooke said the regenerative medicine approach provides proof-of-concept for a small molecule therapy that could one day be used to improve the healing of cardiovascular damage or other injuries.
Other research groups have managed to generate endothelial cells cells using infectious virus particles specially engineered to deliver gene-manipulating DNA to cells. The DNA encodes proteins called transcription factors to alter gene expression patterns in such a way that cells behave more like endothelial cells.
“There are problems with using viruses to transfer genes into cells,” Cooke said. “This gene therapy approach is more complicated, and using viral vectors means the possibility of causing damage to the patient’s chromosomes. We believe a small-molecule approach to transforming the cells will be far more feasible and safer for clinical therapies.”
The Latest on: Reprogrammed cells
[google_news title=”” keyword=”Reprogrammed cells” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Reprogrammed cells
- Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024on May 6, 2024 at 5:00 am
Expect to share initial clinical and translational data from the Phase 1 trial of LYL797, a ROR1-targeted CAR T‑cell product candidate, this quarterOn track to report initial clinical data from the ...
- Engineering Life: Chemists Have Created the Functional Synthetic Cells That Act Like Real Oneson May 3, 2024 at 6:10 pm
Researchers employ cutting-edge methods to create functional cells, closing the divide between synthetic and biological materials. In a new study published in Nature Chemistry, UNC-Chapel Hill researc ...
- How cancer cells harness energy to drive disease progressionon May 3, 2024 at 11:11 am
Researchers have revealed crucial insights into how the Warburg effect causes the dedifferentiation of cancer cells through epigenetic reprogramming. This discovery potentially opens up new avenues ...
- Revealed: How cancer cells harness energy to drive disease progressionon May 2, 2024 at 5:00 pm
Researchers have revealed crucial insights into how the Warburg effect causes the dedifferentiation of cancer cells through epigenetic reprogramming.
- Katsuhiko Hayashion May 2, 2024 at 5:11 am
Katsuhiko Hayashi, a genome scientist at Osaka University, turned that tenet on its head last year when he reprogrammed a male mouse’s cells to develop into eggs. Those eggs were then fertilized with ...
- When does old age begin? Science says later than you might thinkon May 1, 2024 at 8:21 am
Today's 60 year olds don't feel as old as a generation ago. New data suggests old age is more of a social construct than an objective biological reality.
- Cancer cell–immune cell interactions can predict immunotherapy responseon April 29, 2024 at 9:44 am
By examining which genes were turned on and off in a mix of cell types from breast cancer biopsies, a team led by UT Southwestern Medical Center researchers developed a tool that can accurately ...
- Accessible Cell Therapies for Alzheimer's and Parkinson's Diseaseon April 25, 2024 at 10:21 pm
Researchers have now potentially advanced the accessible personalized cell-based therapies for Alzheimer's and Parkinson's diseases.
- Self-assembling synthetic cells act like living cells with extra abilitieson April 23, 2024 at 5:00 pm
Blurring the line between artificial and living materials, these cells can be reprogrammed to perform multiple functions, opening the door to new synthetic biology tech that goes beyond nature’s ...
- Researchers create artificial cells that act like living cellson April 23, 2024 at 9:51 am
In a new study published in Nature Chemistry, UNC-Chapel Hill researcher Ronit Freeman and her colleagues describe the steps they took to manipulate DNA and proteins—essential building blocks of ...
via Bing News